Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
SCNI: Scinai Immunotherapeutics Ltd. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
SCNI
The Story
SCNI
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+99.2% / yr
Operating margin
-573.9%
ROIC
-53.2%
Financially safe
Stretched
Debt / equity
0.30×
Interest coverage
-17.7×
Current ratio
1.35×
Valuation
Unrated
P/E ratio
0.0×
Scinai Immunotherapeutics Ltd.
SCNI
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Scinai Immunotherapeutics Ltd.
SCNI
NASDAQ
·
USD
·
Closed
$0.27
−1.09%
$0.27
−$0.00 (1.09%)
52W Range
3th
pctl
Volume
0.29×
avg
Mkt Cap
359095
USD
P/E
0.0
TTM
Div Yield
–
ann
52W Range
3th
pctl
Volume
0.29×
avg
Market Cap
359095
USD
P/E Ratio
0.0
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings